vaccines comprising nonspecific nucleoside hydrolase polypeptides and sterol 24-c-methyl transferase (smt) for the treatment and diagnosis of leishmaniasis
Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise fusion polypeptides comprising Leishmania antigens, in particular, SMT and NH antigens or immunogenic portions or variants thereof, as well as polynucleotides encoding such fusion polypeptides.